Pulmonary formulations: what remains to be done?

Abstract:

:Significant advances have been made in the last 50 years in developing safe and efficacious aerosol formulations for pulmonary delivery. The key to future innovation may lie at the interface between biology and particle engineering. Improved understanding of biological processes including particle clearance, cellular targeting, intracellular trafficking, and drug absorption are needed to better design formulations that deliver to the "target" with the optimal balance of pharmacodynamic, pharmacokinetic, and safety profiles. More specifically, continued advances are needed in the development of: (1) controlled release formulations; (2) formulations with improved regional targeting within the lungs (e.g., airway versus alveoli and vice versa); (3) formulations containing active targeting moieties; (4) formulation strategies for improving the systemic bioavailability of inhaled macromolecules; (5) formulation strategies for delivering macromolecules, including siRNA and DNA into cells; and (f) formulations with improved dose consistency. It is likely that such innovation will require the development of novel excipients and particle engineering strategies. Future innovation must also take into the account the changing marketplace and the diverse set of customers (patient, healthcare professional, heath authorities, payers, and politicians) who must be satisfied. The pharmacoeconomics of new delivery systems will be closely scrutinized, so it is imperative that cost factors be taken into account. Otherwise, the new technology option may overshoot the evolving inhalation marketplace.

authors

Weers JG,Bell J,Chan HK,Cipolla D,Dunbar C,Hickey AJ,Smith IJ

doi

10.1089/jamp.2010.0838

subject

Has Abstract

pub_date

2010-12-01 00:00:00

pages

S5-23

eissn

1941-2711

issn

1941-2703

journal_volume

23 Suppl 2

pub_type

杂志文章,评审
  • Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations.

    abstract:BACKGROUND:The site of deposition in the respiratory tract for aerosolized, inhaled therapeutic drugs depends on both the particles' aerodynamic size and the patient's breathing pattern. METHODS:In 21 healthy subjects with normal lung function, we evaluated an extremely slow inhalation of a large 9.5-μm MMAD particle ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2008.0711

    authors: Zeman KL,Wu J,Bennett WD

    更新日期:2010-12-01 00:00:00

  • Decreased level of PDCD4 (programmed cell death 4) protein activated cell proliferation in the lung of A/J mouse.

    abstract:BACKGROUND:Programmed cell death 4 (PDCD4), a protein that binds to eukaryotic initiation factor 4A (eIF4A), inhibits the initiation of translation. Although a number of tumor suppressors target transcription, Pdcd4 is the first suppressor targeting protein translation, and has also been suggested to function as a tumo...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2009.0778

    authors: Hwang SK,Minai-Tehrani A,Lim HT,Shin JY,An GH,Lee KH,Park KR,Kim YS,Beck GR Jr,Yang HS,Cho MH

    更新日期:2010-10-01 00:00:00

  • A New Quantitative Method for Evaluating Dry Powder Inhalation Efficiency in Asthma Patients.

    abstract:PURPOSE:Many methods have been developed to evaluate dry powder inhalation techniques and their efficiency for disease control in asthma patients. However, it is difficult to apply these methods to clinical practice and research. In this study, we introduce a simple new method that can be applied to dry powder inhalati...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2014.1193

    authors: Liang Y,Hu H,Tian C,Lei Y,Liu C,Luo F

    更新日期:2016-10-01 00:00:00

  • The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation.

    abstract:BACKGROUND:Inhaled alpha1-antitrypsin (AAT) is being developed for treatment of cystic fibrosis to protect the lungs from excessive free elastase. High drug costs mandate a very efficient aerosol system to deliver a high payload to the airways. The I-neb Adaptive Aerosol Delivery (AAD) System is a portable, electronic,...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2009.0793

    authors: Geller DE,Kesser KC

    更新日期:2010-04-01 00:00:00

  • Inhaled Antibiotic Therapy for the Treatment of Upper Respiratory Tract Infections.

    abstract::Upper respiratory tract infections (URTIs), primarily acute rhinopharyngitis, tonsillitis, adenoiditis, and rhinosinusitis (RS), are major causes of morbidity in both children and adults of any age. In addition to the frequent occurrence of related medical problems and the associated socioeconomic costs, URTIs have a ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,评审

    doi:10.1089/jamp.2016.1300

    authors: Esposito S,Rosazza C,Sciarrabba CS,Principi N

    更新日期:2017-02-01 00:00:00

  • Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients.

    abstract:BACKGROUND:To validate the 'Test of Adherence to Inhalers' (TAI), a 12-item questionnaire designed to assess the adherence to inhalers in patients with COPD or asthma. METHODS:A total of 1009 patients with asthma or COPD participated in a cross-sectional multicenter study. Patients with electronic adherence ≥80% were ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,多中心研究

    doi:10.1089/jamp.2015.1212

    authors: Plaza V,Fernández-Rodríguez C,Melero C,Cosío BG,Entrenas LM,de Llano LP,Gutiérrez-Pereyra F,Tarragona E,Palomino R,López-Viña A,TAI Study Group.

    更新日期:2016-04-01 00:00:00

  • Adapting the Abbreviated Impactor Measurement (AIM) concept to make appropriate inhaler aerosol measurements to compare with clinical data: a scoping study with the "Alberta" idealized throat (AIT) inlet.

    abstract:BACKGROUND:The Abbreviated Impactor Measurement (AIM) concept simplifies determination of aerodynamic size metrics for inhaler quality control testing. A similar approach is needed to compare in vitro particle size distribution metrics with human respiratory tract (HRT) deposition. METHODS:An abbreviated impactor base...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2011.0925

    authors: Mitchell J,Copley M,Sizer Y,Russell T,Solomon D

    更新日期:2012-08-01 00:00:00

  • In vitro characterization of the OptiChamber Diamond valved holding chamber.

    abstract:BACKGROUND:Use of a valved holding chamber (VHC) in conjunction with a pressurized metered dose inhaler (pMDI) can reduce issues relating to poor actuation-inhalation coordination and potentially improve the lung deposition of aerosol, compared with use of a pMDI alone. However, the performance of a VHC is influenced b...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2013.1067

    authors: Hatley RH,von Hollen D,Sandell D,Slator L

    更新日期:2014-08-01 00:00:00

  • Correcting Photo Reflection Method Output and Its Application in the Dynamic Analysis of Particle Release from Dry Powder Inhalers.

    abstract:: Background: The photo reflection method (PRM) is used to measure light reflected from particles released from dry powder inhalers (DPIs). This simple method depicts time trajectories of released drugs; however, it underestimates the number of particles at high peak inhalat...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2020.1610

    authors: Kondo T,Hibino M,Tanigaki T,Tajiri S,Horiuchi S

    更新日期:2020-11-04 00:00:00

  • Vitamin A Supplementation by Endotracheal Application of a Nano-encapsulated Preparation Is Feasible in Ventilated Preterm Lambs.

    abstract:BACKGROUND:Vitamin A (VA) is crucial for lung growth and development. In premature infants, inadequate VA levels are associated with an increased risk of bronchopulmonary dysplasia (BPD). Intramuscular VA supplementation has been shown to decrease the incidence of BPD, but is not widely used in the clinical setting due...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1438

    authors: Wahl HB,Hütten MC,Monz D,Tutdibi E,Ophelders D,Nikiforou M,Tschernig T,Gortner L,Nohr D,Biesalski HK,Kramer BW

    更新日期:2018-12-01 00:00:00

  • Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions.

    abstract:BACKGROUND:Spiromax(®) is a novel dry powder inhaler for patients with asthma or chronic obstructive pulmonary disease (COPD). The studies presented here provide further data on attributes (in vitro dosing consistency with budesonide-formoterol (DuoResp) Spiromax; flow rates through empty versions of the Spiromax and T...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2015.1216

    authors: Canonica GW,Arp J,Keegstra JR,Chrystyn H

    更新日期:2015-10-01 00:00:00

  • Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.

    abstract:BACKGROUND:The delivery of antitubercular drugs through direct lung targeting can lead to reduction in the dose as well as side effects of the drug. In the present investigation, carrier (lactose)-based dry-powder inhaler of rifampicin was prepared to achieve direct targeting of the drug into the lungs. METHODS:The dr...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1379

    authors: Rawal T,Kremer L,Halloum I,Butani S

    更新日期:2017-12-01 00:00:00

  • Model Calculations of Regional Deposition and Disposition for Single Doses of Inhaled Liposomal and Dry Powder Ciprofloxacin.

    abstract:BACKGROUND:Model predictions of regional deposition in the respiratory tract are useful in assessing factors that influence the effectiveness of aerosol delivery. Regional deposition models have previously been coupled with models of mucous production and clearance to estimate initial concentrations of drug deposited i...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1377

    authors: Martin AR,Finlay WH

    更新日期:2018-02-01 00:00:00

  • The Impact of Common Inhaler Errors on Drug Delivery: Investigating Critical Errors with a Dry Powder Inhaler.

    abstract:BACKGROUND:Researchers, using checklists, have identified that 30%-90% of patients make errors in inhaler use. It is not certain whether these errors affect the delivery of medication. We have developed an electronic monitor (INCA™) that records audio each time an inhaler is used, providing objective information on inh...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2016.1334

    authors: Sulaiman I,Seheult J,Sadasivuni N,MacHale E,Killane I,Giannoutsos S,Cushen B,Mokoka MC,Bhreathnach AS,Boland F,Reilly RB,Costello RW

    更新日期:2017-08-01 00:00:00

  • Sustained mechanical and clinical functionality of the flexhaler dry powder inhaler.

    abstract::Flexhaler is a multiple-dose, inspiratory flow-driven dry powder inhaler that is a newer version of Turbuhaler, and is identical to the Symbicort Turbuhaler. Sustained performance is of the utmost importance to ensure consistent drug delivery throughout the lifespan of the inhaler. We report functionality testing resu...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2008.0700

    authors: Lööf T,Elfman P,Ström P,Törngren A,Borgström L

    更新日期:2008-12-01 00:00:00

  • Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.

    abstract:BACKGROUND:The effectiveness of metered-dose inhalers (MDIs) in delivering medication to the lungs highly depends on its correct usage technique. Current guidelines state optimal technique for high lung deposition should include a slow inhalation (>5 seconds) at an inspiratory flow rate of 30 L/min and inhaler actuatio...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2015.1278

    authors: Biswas R,Hanania NA,Sabharwal A

    更新日期:2017-08-01 00:00:00

  • Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.

    abstract:BACKGROUND:The Respimat Soft Mist Inhaler is reported to generate an aerosol with low spray momentum and a small droplet size. However, the transport characteristics of the Respimat aerosol are not well understood. The objective of this study was to characterize the transport and deposition of an aerosol emitted from t...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2008.0708

    authors: Worth Longest P,Hindle M

    更新日期:2009-06-01 00:00:00

  • Collecting exhaled breath condensate (EBC) with two condensers in series: a promising technique for studying the mechanisms of EBC formation, and the volatility of selected biomarkers.

    abstract::Exhaled breath condensate (EBC) consists mainly of water, but also contains semivolatile and nonvolatile compounds. The aim of this study was to develop a system in which two condensers are simultaneously used in series to clarify the mechanisms of EBC condensation. Two aliquots of EBC (EBC1 and EBC2) were collected f...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2007.0644

    authors: Corradi M,Goldoni M,Caglieri A,Folesani G,Poli D,Corti M,Mutti A

    更新日期:2008-03-01 00:00:00

  • Single-dose pharmacokinetics and safety pharmacodynamics of formoterol delivered by two different dry powder inhalers.

    abstract::The present study aimed at assessing the pharmacokinetics (PK) and safety pharmacodynamics (PD) of 24 microg formoterol delivered via a Novolizer and via an Aerolizer in healthy subjects. This was a randomized, open-label, crossover study. Beside PK, serum potassium, and glucose profiles, vital signs, and ECG were rec...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,随机对照试验

    doi:10.1089/jamp.2008.0690

    authors: Petzold U,Kremer HJ,Nguyen DT,Munzel U,Dietrich H,Maus J

    更新日期:2008-09-01 00:00:00

  • Optimal delivery of aerosols to infants during mechanical ventilation.

    abstract:PURPOSE:The objective of this study was to determine optimal aerosol delivery conditions for a full-term (3.6 kg) infant receiving invasive mechanical ventilation by evaluating the effects of aerosol particle size, a new wye connector, and timing of aerosol delivery. METHODS:In vitro experiments used a vibrating mesh ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2013.1077

    authors: Longest PW,Azimi M,Hindle M

    更新日期:2014-10-01 00:00:00

  • Physicochemical and Pharmacokinetic Evaluation of Spray-Dried Coformulation of Salvia miltiorrhiza Polyphenolic Acid and L-Leucine with Improved Bioavailability.

    abstract:: Background: Salvia miltiorrhiza polyphenolic acid (SMPA) is effective in the treatment of cardiovascular diseases and currently it is administered orally or intravenously. However, SMPA is poorly absorbed orally and quickly eliminated in vivo. A long-term frequent intraveno...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2019.1538

    authors: Lu P,Xing Y,Peng H,Liu Z,Zhou QT,Xue Z,Ma Z,Kebebe D,Zhang B,Liu H

    更新日期:2020-04-01 00:00:00

  • Intranasal Deposition of Accuspray™ Aerosol in Anatomically Correct Models of 2-, 5-, and 12-Year-Old Children.

    abstract:BACKGROUND:To our knowledge, quantification of intranasal deposition of aerosol generated by Accuspray(™) (AS) in children has never been published. We hypothesized that deposition would vary significantly with age and with placement of the device within, or outside, of the nostril. METHODS:We tested these hypotheses ...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2014.1174

    authors: Laube BL,Sharpless G,Vikani AR,Harrand V,Zinreich SJ,Sedberry K,Knaus D,Barry J,Papania M

    更新日期:2015-10-01 00:00:00

  • Development of an in vitro model to assess deposition of aerosol particles in a representative replica of the rat's respiratory tract.

    abstract:BACKGROUND:Small rodents continue to be the mainstay for the assessment of pharmacological and toxicological data of inhaled therapeutics. For meaningful interpretation of the results information about deposition of aerosol particles in the respiratory tract is warranted, but not trivial to obtain for animals with nose...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2011.0902

    authors: Ahmed A,Prime D,Burnell PK,Högger P

    更新日期:2012-06-01 00:00:00

  • Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.

    abstract:BACKGROUND:Understanding the regional partition of deposition of inhaled particles within the lung is important for improving targeted delivery of inhaled aerosolized drugs. One factor affecting regional deposition is gravity. As the lung deforms under its own weight, changes in lung volume, in airway geometries, and i...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2014.1189

    authors: Sá RC,Zeman KL,Bennett WD,Prisk GK,Darquenne C

    更新日期:2015-12-01 00:00:00

  • Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform.

    abstract:: Background: Many substances used in inhalation research are water soluble and can be administered as nebulized solutions. Typical examples are therapeutic, small-molecular agents, or macromolecules. Another category is a number of water-soluble agents used for airway diagn...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2019.1554

    authors: Gerde P,Nowenwik M,Sjöberg CO,Selg E

    更新日期:2020-04-01 00:00:00

  • Assessment of the Power Required for Optimal Use of Current Inhalation Devices.

    abstract:: Background: Inhalation of medications is the cornerstone in the treatment of patients with lung diseases. A variety of inhalation devices exists and each device has specific requirements to achieve optimum inhalation of the drug. The goal of this study was to establish a c...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2017.1376

    authors: Pohlmann G,Hohlfeld JM,Haidl P,Pankalla J,Cloes RM

    更新日期:2018-12-01 00:00:00

  • Pulmonary Toxicity of Benzalkonium Chloride.

    abstract::The available toxicity data of benzalkonium chloride (BKC) clearly shows that it is toxic; however, the weight of evidence favors the view that at doses encountered in nasally and orally inhaled pharmaceutical preparations it is well tolerated. The adverse toxicological data predominantly come from in vitro and animal...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章,评审

    doi:10.1089/jamp.2017.1390

    authors: Johnson NF

    更新日期:2018-02-01 00:00:00

  • Characterization of Medication Velocity and Size Distribution from Pressurized Metered-Dose Inhalers by Phase Doppler Anemometry.

    abstract:BACKGROUND:Particle size and velocity are two of the most significant factors that impact the deposition of pressurized metered-dose inhaler (pMDI) sprays in the mouth cavity. pMDIs are prominently used around the world in the treatment of patients suffering from a variety of lung diseases such as asthma and chronic ob...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2015.1264

    authors: Alatrash A,Matida E

    更新日期:2016-12-01 00:00:00

  • Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex.

    abstract::Antibiotic-resistant bacterial infections have renewed interest in finding substitute methods of treatment. The purpose of the present in vitro study was to investigate the possibility of respiratory delivery of a Burkholderia cepacia complex (BCC) bacteriophage by nebulized aerosol administration. Bacteriophages in i...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2008.0701

    authors: Golshahi L,Seed KD,Dennis JJ,Finlay WH

    更新日期:2008-12-01 00:00:00

  • Deposition Mechanisms.

    abstract::The success of inhalation therapy is not only dependent upon the pharmacology of the drugs being inhaled but also upon the site and extent of deposition in the respiratory tract. Similarly, the toxicity of environmental and industrial particulate matter is affected not only by the nature of the dust but also by the am...

    journal_title:Journal of aerosol medicine and pulmonary drug delivery

    pub_type: 杂志文章

    doi:10.1089/jamp.2020.29029.cd

    authors: Darquenne C

    更新日期:2020-08-01 00:00:00